Paul J. Wang, MD
Academic Appointments
- Professor - Med Center Line, Medicine - Cardiovascular Medicine
- Professor - Med Center Line (By courtesy), Bioengineering
Key Documents
Contact Information
-
Clinical Offices
Cardiovascular Medicine Clinic 300 Pasteur Dr MC 5319 A260 Stanford, CA 94305 Tel Work (650) 723-6459 Fax (650) 723-8392
- Academic Offices
Personal Information Email Tel (650) 723-9363Not for medical emergencies or patient use
Professional Overview
Clinical Focus
- Cardiac Electrophysiology
- Cardiology (Heart)
- Atrial Fibrillation
- Cardiac Arrhythmias
- Implantable Defibrillators
Professional Education
| Board Certification: | Clinical Cardiac Electrophysiology, American Board of Internal Medicine (1992) |
| Board Certification: | Internal Medicine, American Board of Internal Medicine (1986) |
| Fellowship: | Brigham and Women's Hospital, Harvard Medical School MA (1989) |
| Internship: | New York Presbyterian Medical Center NY (1984) |
| Medical Education: | College of Physicians & Surgeons, Columbia University NY (1983) |
Postdoctoral Advisees
Scientific Focus
Current Research Interests
Dr. Wang's research centers on the development of innovative approaches to the treatment of arrhythmias, including more effective catheter ablation techniques, more reliable implantable devices, and less invasive treatments. Dr. Wang's clinical research interests include atrial fibrillation, ventricular tachycardia, syncope, and hypertrophic cardiomyopathy. Dr. Wang has active collaborations with Bioengineering, Mechanical Engineering, and Electrical Engineering Departments at Stanford. Some of the goals of his research program are: 1) to create a more effective methods of catheter ablation, 2) to create implantable pacemakers and leads that are more reliable, 3) to create a combined surgical-catheter approach to ablation, 4) to create noninvasive methods of ablation, 5) to make defibrillation painless.
Clinical Trials
- CardioFocus Endoscopic Ablation System - AC Pivotal Study Recruiting
- Catheter ABlation Versus Antiarrhythmic Drug Therapy For Atrial Fibrillation Trial (CABANA) Recruiting
- A Clinical Study of the Arctic Front Cryoablation Balloon for the Treatment of Paroxysmal Atrial Fibrillation No longer recruiting
- To assess the safety and technical feasibility of treating subjects with Persistent Atrial Fibrillation or Longstanding Persistent Atrial Fibrillation using a hybrid approach of epicardial and endocardial ablation. No longer recruiting
Publications
- A novel method for patient-specific QTc--modeling QT-RR hysteresis. Ann Noninvasive Electrocardiol. 2011; (1): 3-12
- Cost-effectiveness of dabigatran compared with warfarin for stroke prevention in atrial fibrillation. Ann Intern Med. 2011; (1): 1-11
- Cost-effectiveness of genetic testing in family members of patients with long-QT syndrome. Circ Cardiovasc Qual Outcomes. 2011; (1): 76-84
- Effectiveness of Cardiac Resynchronization Therapy by QRS Morphology in the Multicenter Automatic Defibrillator Implantation Trial-Cardiac Resynchronization Therapy (MADIT-CRT). Circulation. 2011; (10): 1061-72
- Subcutaneous implantable cardioverter-defibrillator technology. Heart Fail Clin. 2011; (2): 287-94, x
